Jump to ContentJump to Main Navigation
Show Summary Details
More options …

International Journal of Adolescent Medicine and Health

Editor-in-Chief: Merrick, Joav

Editorial Board: Birch, Diana ML / Blum, Robert W. / Greydanus, MD, Dr. HC (Athens), Donald E. / Hardoff, Daniel / Kerr, Mike / Levy, Howard B / Morad, Mohammed / Omar, Hatim A. / de Paul, Joaquin / Rydelius, Per-Anders / Shek, Daniel T.L. / Sher, Leo / Silber, Tomas J. / Towns, Susan / Urkin, Jacob / Verhofstadt-Deneve, Leni / Zeltzer, Lonnie / Tenenbaum, Ariel


CiteScore 2018: 0.79

SCImago Journal Rank (SJR) 2018: 0.350
Source Normalized Impact per Paper (SNIP) 2018: 0.476

Online
ISSN
2191-0278
See all formats and pricing
More options …
Volume 30, Issue 2

Issues

Immune status of representative infectious diseases among Japanese female university students

Misaki Katsuyama / Yuji Koike / Toshie Hirohara / Kazuhiro Kogawa
Published Online: 2016-08-05 | DOI: https://doi.org/10.1515/ijamh-2016-0038

Abstract

Objective:

To elucidate the immune status of representative infectious diseases among Japanese youth, we retrospectively investigated serum antibody levels in university students, partly comparing these to immunization records and infectious disease histories confirmed by the maternal and child health (MCH) handbooks.

Materials and methods:

In total, 168 Japanese female university students, aged 20–21 years, were included. Data were collected from examinations of antibody titers against measles, rubella, varicella-zoster (VZ), mumps, and hepatitis B (HB) and C (HC) viruses, and from QuantiFERON®-TB Gold tests, between 2011 and 2015. Records of immunization and infectious disease histories were available from MCH handbooks for students who agreed with the use of their data for this study (n=23).

Results:

All students had positive antibodies, detected by enzyme immunoassay (EIA), against measles, rubella, VZ, and mumps; however, seroprevalences within the range of seroprotective antibody levels were 38.1% (64/168), 67.9% (114/168), 95.9% (141/147), and 89.8% (132/147), respectively. The students had probably not been infected with HB, HC, or tuberculosis at the time of the examinations.

Discussion:

The study indicated that a two-dose vaccine for measles and rubella (MR) might not be sufficient to produce antibodies at seroprotective levels. Therefore, we propose that health care workers, including students, should receive an additional MR vaccine, even if they have received two doses of MR vaccine or if they have unknown histories of immunizations or infectious diseases. Further investigations in these areas will be needed.

Keywords: enzyme immunoassay (EIA); health care worker; seroprotective

References

  • 1.

    Maglione MA, Das L, Raaen L, Smith A, Chari R, et al. Safety of vaccines used for routine immunization of US children: a systematic review. Pediatrics 2014;134:325–37.CrossrefWeb of ScienceGoogle Scholar

  • 2.

    Japan Pediatric Society. Vaccination schedule recommended by the Japan Pediatric Society (Oct. 1.2014). Available at: http://www.jpeds.or.jp/modules/activity/index.php?content_id=138.

  • 3.

    Ministry of Health, Labour and Welfare. Infectious disease surveillance (in Japanese). Available at: http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/kekkaku-kansenshou/.

  • 4.

    Yanagisawa S, Soyano A, Igarashi H, Ura M, Nakamura Y. Effect of a maternal and child health handbook on maternal knowledge and behaviour: a community-based controlled trial in rural Cambodia. Health Policy Plan 2015;30:1184–92.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 5.

    Kito H. Guidance for education on medicines in school. Yakugaku Zasshi 2013;133:1319–23.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 6.

    Japanese Society for Infection Prevention and Control. Vaccine guideline for health care workers, 2nd ed. (in Japanese). Jpn J Environ Infect 2014;29(Suppl. III):s1–14.Google Scholar

  • 7.

    Date AA, Kyaw MH, Rue AM, Klahn J, Obrecht L, et al. Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Infect Dis 2008;197:1662–8.CrossrefWeb of SciencePubMedGoogle Scholar

  • 8.

    Sheek-Hussein M, Hashmey R, Alsuwaidi AR, Al Maskari F, Amiri L, et al. Seroprevalence of measles, mumps, rubella, varicella-zoster and hepatitis A-C in Emirati medical students. BMC Public Health 2012;12:1047–52.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 9.

    Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol 2010;17:1055–65.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 10.

    Garman L, Vineyard AJ, Crowe SR, Harley JB, Spooner CE, et al. Humoral responses to independent vaccinations are correlated in healthy boosted adults. Vaccine 2014;32:5624–31.CrossrefWeb of SciencePubMedGoogle Scholar

  • 11.

    Torner N, Solano R, Rius C, Domínguez A, Surveillance Network Of Catalonia Spain TM. Implication of health care personnel in measles transmission. Hum Vaccin Immunother 2015;11:288–92.CrossrefPubMedGoogle Scholar

  • 12.

    Dorigo-Zetsma JW, Leverstein-van Hall MA, Vreeswijk J, de Vries JJ, Vossen AC, et al. Immune status of health care workers to measles virus: evaluation of protective titers in four measles IgG EIAs. J Clin Virol 2015;69:214–8.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 13.

    Poethko-Müller C, Mankertz A. Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity. PLoS One 2012;7:e42867.Web of ScienceCrossrefPubMedGoogle Scholar

  • 14.

    Ihara T. The strategy for prevention of measles and rubella prevalence with measles-rubella (MR) vaccine in Japan. Vaccine 2009;27:3234–6.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 15.

    Kumagai T, Ihara T, Nakayama T, Nagata N, Kamiya H. Reactogenicity and immunogenicity of measles-rubella combined vaccine in school-entry-aged subjects with naturally acquired measles immunity. Pediatr Int 2015;57:597–602.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 16.

    Gohil DJ, Kothari ST, Chaudhari AB, Gunale BK, Kulkarni PS, et al. Seroprevalence of measles, mumps, and rubella antibodies in college students in Mumbai, India. Viral Immunol 2016;29:159–63.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 17.

    Kimura T, Tsunekawa K, Ogiwara T, Tokue Y, Nara M, et al. Seroprevalence of measles- and mumps-specific immunoglobulin G among Japanese healthcare students increased during 2007–2012. Jpn J Infect Dis 2013;66:411–5.Web of SciencePubMedCrossrefGoogle Scholar

  • 18.

    National Institute of Infectious Diseases. Japan Infectious Surveillance Center,Infectious diseases weekly report. Available at: http://www.nih.go.jp/niid/ja/data.html.

  • 19.

    Tanaka J, Koyama T, Mizui M, Uchida S, Katayama K, et al. Total numbers of undiagnosed carriers of hepatitis C and B viruses in Japan estimated by age- and area-specific prevalence on the national scale. Intervirology 2011;54:185–95.CrossrefWeb of ScienceGoogle Scholar

  • 20.

    Eguchi H, Wada K. Knowledge of HBV and HCV and individuals’ attitudes toward HBV- and HCV-infected colleagues: a national cross-sectional study among a working population in Japan. PLoS One 2013;8:e76921.Web of SciencePubMedCrossrefGoogle Scholar

  • 21.

    Ogiwara T, Kimura T, Tokue Y, Watanabe R, Nara M, et al. Tuberculosis screening using a T-cell interferon-γ release assay in Japanese medical students and non-Japanese international students. Tohoku J Exp Med 2013;230:87–91.CrossrefWeb of SciencePubMedGoogle Scholar

About the article

Corresponding author: Yuji Koike, MD, PhD, Department of Health and Education, Ibaraki University College of Education, 2-1-1 Bunkyo, Mito, Ibaraki 310-8512, Japan, Tel/Fax: +81-29-228-8295


Received: 2016-04-12

Accepted: 2016-06-29

Published Online: 2016-08-05


Citation Information: International Journal of Adolescent Medicine and Health, Volume 30, Issue 2, 20160038, ISSN (Online) 2191-0278, DOI: https://doi.org/10.1515/ijamh-2016-0038.

Export Citation

©2018 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Negin Rahmani, Afagh Moattari, Neda Pirbonyeh, Vida Keshavarzi, and Golnoush Sadat Mahmoudi Nezhad
Zahedan Journal of Research in Medical Sciences, 2019, Volume 21, Number 3

Comments (0)

Please log in or register to comment.
Log in